(Q54017862)

23 May 2018

title

Effect of acarbose on additional insulin therapy in type 2 diabetic patients with late failure of sulphonylurea therapy. (English)

1 reference

23 May 2018

0 references

1 reference

1 reference

Standl E

1

1 reference

23 May 2018

Baumgartl HJ

series ordinal

2

1 reference

23 May 2018

Füchtenbusch M

series ordinal

3

1 reference

23 May 2018

Stemplinger J

series ordinal

4

1 reference

23 May 2018

publication date

1 July 1999

1 reference

23 May 2018

Diabetes, Obesity and Metabolism

published in

1 reference

23 May 2018

volume

1

1 reference

23 May 2018

issue

4

1 reference

23 May 2018

page(s)

215-220

1 reference

23 May 2018

Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00021.X

Effect of the?? glucosidase-inhibitor BAY-g-5421 on blood glucose control of sulphonylurea-treated diabetics and insulin-treated diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00021.X

Effect of acarbose on carbohydrate and lipid metabolism in NIDDM patients poorly controlled by sulfonylureas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00021.X

Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00021.X

Human C-peptide immunoreactivity (CPR) in blood and urine - evaluation of a radioimmunoassay method and its clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00021.X

Insulin resistance--a secret killer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00021.X

The effect of acarbose on insulin sensitivity and proinsulin in overweight subjects with impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00021.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.00021.X

10.1046/J.1463-1326.1999.00021.X

21 January 2018

Identifiers

DOI

1 reference

23 May 2018

1 reference

23 May 2018